The Nightview Fund's 2024 annual letter explores five transformative trends they are tracking in 2025 and beyond. Click here ...

Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital ...

Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, “Formycon”) today published its audited consolidated financial statements for the 2024 financial year and provided an outlook for fiscal year 2025 ...

Q4 2024 Earnings Call Transcript March 27, 2025 BioAtla, Inc. beats earnings expectations. Reported EPS is $-0.285, ...

Ford Motor remains a strong long-term investment with its growing EV sales, 6% dividend yield, and competitive valuation.

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

Valaris Limited (NYSE: VAL) ("Valaris" or the "Company") announced today that it has been awarded a two-year contract ...

Dr. Stefan Glombitza, CEO of Formycon AG, said: “2024 was a year marked by significant milestones for Formycon and substantial progress in our product pipeline ... Our entire pipeline continues to ...

Q4 2024 Earnings Call Transcript March 27, 2025 Telesat Corporation misses on earnings expectations. Reported EPS is $-5.9 ...

James Ratcliffe; Vice President of Investor Relations; Telesat Corp. Daniel Goldberg; President, Chief Executive Officer, Director; Telesat Corp. Andrew Browne; Chie ...

According to data from OpenInsider, stocks with concentrated insider buying activity have historically outperformed the ...